| 臺大學術典藏 |
2022-01-24T09:31:04Z |
Successful antiviral therapy reduces risk of schizophrenia among chronic hepatitis c patients: A nationwide real-world Taiwanese cohort (T-COACH)
|
Tsai P.-C.; Chen C.-Y.; Kuo H.-T.; Hung C.-H.; Tseng K.-C.; Lai H.-C.; Peng C.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; Kao J.-H.; CHUN-JEN LIU; Liu C.-H.; Yan S.-L.; Bair M.-J.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Tai C.-M.; Lin C.-W.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang C.-F.; Hsieh M.-H.; Huang J.-F.; Dai C.-Y.; Chung W.-L.; Ke C.-L.K.; Yu M.-L.; T-COACH Study Group |
| 臺大學術典藏 |
2022-01-24T09:31:03Z |
Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis
|
Hsu W.-F.; Chen C.-Y.; Tseng K.-C.; Lai H.-C.; Kuo H.-T.; Hung C.-H.; Tung S.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Lin C.-Y.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; Kao J.-H.; CHUN-JEN LIU; Liu C.-H.; Yan S.-L.; Bair M.-J.; Su W.-W.; Chu C.-H.; Chen C.-J.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Tsai P.-C.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Yu M.-L.; Peng C.-Y. |
| 臺大學術典藏 |
2022-01-24T09:31:03Z |
Longitudinal change of metabolite profile and its relation to multiple risk factors for the risk of developing hepatitis B-related hepatocellular carcinoma
|
Huang B.-Y.; Tsai M.-R.; Hsu J.-K.; Lin C.-Y.; Lin C.-L.; Hu J.-T.; Huang Y.-W.; CHUN-JEN LIU; Wu W.-J.; Wu C.-F.; Sung F.-Y.; Chen P.-J.; Liang H.-J.; Lin S.-M.; Yu M.-W. |
| 臺大學術典藏 |
2022-01-24T09:31:03Z |
High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy
|
Chang W.-Y.; Chiu Y.-C.; Chiu F.-W.; Hsu Y.-C.; Tseng T.-C.; Cheng P.-N.; Yang S.-S.; CHUN-JEN LIU; Su T.-H.; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:02Z |
Clinical and histologic features of patients with biopsy-proven metabolic dysfunction-associated fatty liver disease
|
Huang S.-C.; Su H.-J.; Kao J.-H.; Tseng T.-C.; Yang H.-C.; Su T.-H.; Chen P.-J.; CHUN-JEN LIU |
| 臺大學術典藏 |
2022-01-24T09:31:02Z |
Sofosbuvir/velpatasvir/voxilaprevir plus ribavirin for chronic hepatitis C patients with direct acting antiviral failures: Implications for viral elimination in Taiwan
|
Liu C.-H.; Su T.-H.; CHUN-JEN LIU; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:02Z |
Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis
|
Liu C.-H.; Peng C.-Y.; Fang Y.-J.; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; Su T.-H.; CHUN-JEN LIU; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:01Z |
Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agents
|
Huang S.-C.; Cheng P.-N.; Liu C.-H.; Yang H.-C.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Kao J.-H.; CHUN-JEN LIU |
| 臺大學術典藏 |
2022-01-24T09:31:01Z |
Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosis
|
Su T.-H.; Peng C.-Y.; Chang S.-H.; Tseng T.-C.; CHUN-JEN LIU; Chen C.-L.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:01Z |
Kinetics of hepatitis B surface antigen in pregnant women with and without tenofovir disoproxil fumarate
|
Chang H.-L.; Wen W.-H.; Lee C.-N.; Chiu Y.-E.; CHUN-JEN LIU; Chang M.-H.; Lin L.-H.; Chen H.-L. |
| 臺大學術典藏 |
2022-01-24T09:31:01Z |
Changing epidemiology of liver disease in Asia: Dual infection of HBV and HCV
|
CHUN-JEN LIU; Chen P.-J. |
| 臺大學術典藏 |
2022-01-24T09:31:00Z |
Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR)
|
Huang C.-F.; Tseng K.-C.; Cheng P.-N.; Hung C.-H.; Lo C.-C.; Peng C.-Y.; Bair M.-J.; Yeh M.-L.; Chen C.-H.; Lee P.-L.; Lin C.-Y.; Kuo H.-T.; Chen C.-T.; Yang C.-C.; Huang J.-F.; Tai C.-M.; Hu J.-T.; Lin C.-L.; Su W.-W.; Tsai W.-L.; Huang Y.-H.; Cheng C.-Y.; Lin C.-L.; Wang C.-C.; Yang S.-S.; Mo L.-R.; Chen G.-Y.; Chang C.-C.; Wang S.-J.; Huang C.-S.; Hsieh T.-Y.; Lin C.-W.; Lee T.-H.; Chong L.-W.; Huang C.-W.; Chang S.-N.; Tsai M.-C.; Hsu S.-J.; Kao J.-H.; CHUN-JEN LIU; Liu C.-H.; Lin H.-C.; Lee M.-H.; Tsai P.-C.; Dai C.-Y.; Chuang W.-L.; Chen C.-Y.; Yu M.-L. |
| 臺大學術典藏 |
2022-01-24T09:31:00Z |
Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment
|
Liu C.-H.; Peng C.-Y.; Kao W.-Y.; Yang S.-S.; Shih Y.-L.; Lin C.-L.; Tsai M.-K.; Lee C.-Y.; Chang C.-C.; Wu J.-H.; CHUN-JEN LIU; Su T.-H.; Tseng T.-C.; Chen P.-J.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:00Z |
Hepatic steatosis and development of type 2 diabetes: Impact of chronic hepatitis B and viral specific factors
|
Yu M.-W.; Lin C.-L.; CHUN-JEN LIU; Huang Y.-W.; Hu J.-T.; Wu W.-J.; Wu C.-F. |
| 臺大學術典藏 |
2022-01-24T09:30:59Z |
Sofosbuvir/Velpatasvir for Hepatitis?C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
|
Cheng P.-N.; Mo L.-R.; Chen C.-T.; Chen C.-Y.; Huang C.-F.; Kuo H.-T.; Lo C.-C.; Tseng K.-C.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Chang T.S.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Chou K.-H.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Cheng C.-Y.; Tsai M.-C.; CHUN-JEN LIU; Dai C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L.; Yu M.-L.; TACR investigators |
| 臺大學術典藏 |
2022-01-24T09:30:59Z |
Hepatocellular carcinoma after treatment cessation in non-cirrhotic HBeAg-negative chronic hepatitis B: A multicentre cohort study
|
Papatheodoridi M.; Su T.-H.; Hadziyannis E.; Liao C.-H.; Orfanidou Α.; Yang H.-C.; Zachou K.; CHUN-JEN LIU; Kourikou A.; Gatselis N.; Manolakopoulos S.; Dalekos G.; Kao J.-H.; Hadziyannis S.; Papatheodoridis G.V. |
| 臺大學術典藏 |
2022-01-24T09:30:58Z |
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
|
Liu C.-H.; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; CHUN-JEN LIU; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; Fang Y.-J.; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; Hung C.-C.; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T.?Y.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:30:58Z |
Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load
|
Tseng T.-C.; CHUN-JEN LIU; Yang W.-T.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; Chen H.-H.; Chen P.-J.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:30:58Z |
Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Shao Y.-Y.; Wang S.-Y.; Lin S.-M.; Chen K.-Y.; Tseng J.-H.; Ho M.-C.; Lee R.-C.; Liang P.-C.; Liao L.-Y.; Huang K.-W.; Hu J.-T.; Liang J.-D.; Kee K.-M.; Lin C.-L.; Wang C.-K.; Lu S.-N.; Wang J.-H.; Lee W.-C.; Chen C.-H.; CHUN-JEN LIU; Huang Y.-H.; Wang C.-C.; Wang T.-E.; Chuang P.-H.; Dai C.-Y.; Hsu C.; Chen S.-C.; Hsieh C.-H.; Diagnosis Group, Systemic Therapy Group |
| 臺大學術典藏 |
2022-01-24T09:30:57Z |
Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan
|
Chen C.-Y.; Huang C.-F.; Cheng P.-N.; Tseng K.-C.; Lo C.-C.; Kuo H.-T.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Chen C.-T.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Mo L.-R.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Hsiung C.-K.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; CHUN-JEN LIU; Dai C.-Y.; Kao J.-H.; Chuang W.-L.; Lin H.-C.; Yu M.-L. |
| 臺大學術典藏 |
2022-01-24T09:30:57Z |
Mining Gut Microbiota From Bariatric Surgery for MAFLD
|
Wu W.-K.; Chen Y.-H.; Lee P.-C.; Yang P.-J.; Chang C.-C.; Liu K.-L.; Hsu C.-C.; Huang C.-C.; Chuang H.-L.; Sheen L.-Y.; CHUN-JEN LIU; Wu M.-S. |
| 臺大學術典藏 |
2022-01-24T09:30:56Z |
Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients
|
Cheng H.-R.; Yang H.-C.; Lin S.-R.; Yang T.-Y.; Lin Y.-Y.; Su T.-H.; Tseng T.-C.; CHUN-JEN LIU; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:30:56Z |
Whole genome deep sequencing analysis of viral quasispecies diversity and evolution in HBeAg seroconverters
|
Lin S.-R.; Yang T.-Y.; Peng C.-Y.; Lin Y.-Y.; Dai C.-Y.; Wang H.-Y.; Su T.-H.; Tseng T.-C.; Liu I.-J.; Cheng H.-R.; Shen Y.-C.; Wu F.-Y.; CHUN-JEN LIU; Chen D.-S.; Chen P.-J.; Yang H.-C.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:30:56Z |
Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct-acting antivirals and antiretroviral therapy
|
Liu C.-H.; Sun H.-Y.; Hsieh S.-M.; Liu W.-C.; Sheng W.-H.; CHUN-JEN LIU; Su T.-H.; Tseng T.-C.; Chen P.-J.; Hung C.-C.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:30:55Z |
Gut-flora metabolites is not associated with synchronous carotid artery plaque and non-alcoholic fatty liver disease in asymptomatic adults: A STROBE-compliant article
|
Lin Y.-C.; Wang H.-Y.; Kuo Y.-C.; Chen M.-J.; Wu M.-S.; CHUN-JEN LIU; Yang H.W.; Shih S.-C.; Yu L.-Y.; Ko H.-J.; Yeh H.-I.; Hu K.-C. |
| 臺大學術典藏 |
2022-01-24T09:30:55Z |
Long-term risk of end-stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan
|
Hsieh M.-H.; Bair M.-J.; Tsai P.-C.; Tseng K.-C.; Lo C.-C.; Chen C.-Y.; Kuo H.-T.; Hung C.-H.; Lai H.-C.; Peng C.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; Kao J.-H.; CHUN-JEN LIU; Liu C.-H.; Yan S.-L.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Tai C.-M.; Lin C.-W.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang C.-F.; Huang J.-F.; Dai C.-Y.; Yu M.-L.; Chuang W.-L.; T-COACH investigators |
| 臺大學術典藏 |
2022-01-24T09:30:55Z |
Elbasvir/grazoprevir is effective and tolerable for the treatment of HCV GT1-infected patients: A real world multicenter observatory study in Taiwan
|
Cheng P.-N.; Chen C.-Y.; Yu M.-L.; Lin C.-C.; Lin C.-Y.; Peng C.-Y.; Tseng K.-C.; Lo C.-C.; Tseng I.-H.; CHUN-JEN LIU |
| 臺大學術典藏 |
2022-01-24T09:30:55Z |
Molecular mechanisms and animal models of HBV-related hepatocellular carcinoma: With emphasis on metastatic tumor antigen 1
|
Li Y.-T.; Wu H.-L.; CHUN-JEN LIU |
| 臺大學術典藏 |
2022-01-24T09:30:54Z |
Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort)
|
Hsu W.-F.; Tsai P.-C.; Chen C.-Y.; Tseng K.-C.; Lai H.-C.; Kuo H.-T.; Hung C.-H.; Tung S.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Lin C.-Y.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; Kao J.-H.; CHUN-JEN LIU; Liu C.-H.; Yan S.-L.; Bair M.-J.; Su W.-W.; Chu C.-H.; Chen C.-J.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Yu M.-L.; Peng C.-Y. |
| 臺大學術典藏 |
2022-01-24T09:30:54Z |
Investigating the prevalence and clinical effects of hepatitis delta viral infection in Taiwan
|
Lee W.-C.; Chen T.-K.; Han H.-F.; Lin Y.-C.; Hwang Y.-M.; Kao J.-H.; Chen P.-J.; CHUN-JEN LIU |
| 臺大學術典藏 |
2022-01-24T09:30:53Z |
Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)
|
Yeh M.-L.; Hung C.-H.; Tseng K.-C.; Lai H.-C.; Chen C.-Y.; Kuo H.-T.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; Kao J.-H.; Liu C.-H.; Yan S.-L.; Bair M.-J.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Huang C.-F.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Tsai P.-C.; Peng C.-Y.; CHUN-JEN LIU; Yu M.-L. |
| 臺大學術典藏 |
2022-01-24T09:30:53Z |
Sofosbuvir/velpatasvir plus ribavirin for child-pugh b and child-pugh c hepatitis c virus-related cirrhosis
|
Liu C.-H.; Chen C.-Y.; Su W.-W.; CHUN-JEN LIU; Lo C.-C.; Huang K.-J.; Chen J.-J.; Tseng K.-C.; Chang C.-Y.; Peng C.-Y.; Shih Y.-L.; Huang C.-S.; Kao W.-Y.; Yang S.-S.; Tsai M.-C.; Wu J.-H.; Chen P.-Y.; Su P.-Y.; Hwang J.-J.; Fang Y.-J.; Lee P.-L.; Tseng C.-W.; Lee F.-J.; Lai H.-C.; Hsieh T.-Y.; Chang C.-C.; Chang C.-H.; Huang Y.-J.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:30:52Z |
Correction to: Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients (Hepatology International, (2021), 15, 3, (582-592), 10.1007/s12072-021-10186-7)
|
Cheng H.-R.; Yang H.-C.; Lin S.-R.; Yang T.-Y.; Lin Y.-Y.; Su T.-H.; Tseng T.-C.; CHUN-JEN LIU; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:30:52Z |
Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan
|
Huang C.-F.; Kuo H.-T.; Chang T.-S.; Lo C.-C.; Hung C.-H.; Huang C.-W.; Chong L.-W.; Cheng P.-N.; Yeh M.-L.; Peng C.-Y.; Cheng C.-Y.; Huang J.-F.; Bair M.-J.; Lin C.-L.; Yang C.-C.; Wang S.-J.; Hsieh T.-Y.; Lee T.-H.; Lee P.-L.; Wu W.-C.; Lin C.-L.; Su W.-W.; Yang S.-S.; Wang C.-C.; Hu J.-T.; Mo L.-R.; Chen C.-T.; Huang Y.-H.; Chang C.-C.; Huang C.-S.; Chen G.-Y.; Kao C.-N.; Tai C.-M.; CHUN-JEN LIU; Lee M.-H.; Tsai P.-C.; Dai C.-Y.; Kao J.-H.; Lin H.-C.; Chuang W.-L.; Chen C.-Y.; Tseng K.-C.; Yu M.-L. |
| 臺大學術典藏 |
2022-01-24T09:30:52Z |
Drug resistance profile and clinical features for hepatitis C patients experiencing DAA failure in Taiwan
|
Hong C.-M.; Lin Y.-Y.; CHUN-JEN LIU; Lai Y.-Y.; Yeh S.-H.; Yang H.-C.; Kao J.-H.; Hsu S.-J.; Huang Y.-H.; Yang S.-S.; Kuo H.-T.; Cheng P.-N.; Yu M.-L.; Chen P.-J. |
| 臺大學術典藏 |
2022-01-24T09:30:51Z |
Entecavir Prevents HBV Reactivation During Direct Acting Antivirals for HCV/HBV Dual Infection: A Randomized Trial
|
Cheng P.-N.; CHUN-JEN LIU; Chen C.-Y.; Tseng K.-C.; Lo C.-C.; Peng C.-Y.; Lin C.-L.; Chiu H.-C.; Chiu Y.-C.; Chen P.-J. |
| 臺大學術典藏 |
2022-01-15T00:07:58Z |
Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan
|
Huang, Chung Feng; Kuo, Hsing Tao; Chang, Te Sheng; Lo, Ching Chu; Hung, Chao Hung; Huang, Chien Wei; Chong, Lee Won; Cheng, Pin Nan; Yeh, Ming Lun; Peng, Cheng Yuan; Cheng, Chien Yu; Huang, Jee Fu; Bair, Ming Jong; Lin, Chih Lang; Yang, Chi Chieh; Wang, Szu Jen; Hsieh, Tsai Yuan; Lee, Tzong Hsi; Lee, Pei Lun; Wu, Wen Chih; Lin, Chih Lin; Su, Wei Wen; Yang, Sheng Shun; CHIA-CHI WANG; Hu, Jui Ting; Mo, Lein Ray; CHUN-TING CHEN; Huang, Yi Hsiang; Chang, Chun Chao; Huang, Chia Sheng; Chen, Guei Ying; Kao, Chien Neng; Tai, Chi Ming; CHUN-JEN LIU; Lee, Mei Hsuan; Tsai, Pei Chien; Dai, Chia Yen; JIA-HORNG KAO; Lin, Han Chieh; Chuang, Wang Long; Chen, Chi Yi; Tseng, Kuo Chih; Yu, Ming Lung |
| 臺大學術典藏 |
2022-01-15T00:07:58Z |
Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
|
Cheng, Pin Nan; Mo, Lein Ray; CHUN-TING CHEN; Chen, Chi Yi; Huang, Chung Feng; Kuo, Hsing Tao; Lo, Ching Chu; Tseng, Kuo Chih; Huang, Yi Hsiang; Tai, Chi Ming; Peng, Cheng Yuan; Bair, Ming Jong; CHIEN-HUNG CHEN; Yeh, Ming Lun; Lin, Chih Lang; Lin, Chun Yen; Lee, Pei Lun; Chong, Lee Won; Hung, Chao Hung; Chang, Te Sheng; Huang, Jee Fu; Yang, Chi Chieh; Hu, Jui Ting; Lin, Chih Wen; CHIA-CHI WANG; Su, Wei Wen; Hsieh, Tsai Yuan; Lin, Chih Lin; Tsai, Wei Lun; Lee, Tzong Hsi; Chen, Guei Ying; Wang, Szu Jen; Chang, Chun Chao; Yang, Sheng Shun; Wu, Wen Chih; Huang, Chia Sheng; Chou, Kwok Hsiung; Kao, Chien Neng; Tsai, Pei Chien; CHEN-HUA LIU; Lee, Mei Hsuan; Cheng, Chien Yu; Tsai, Ming Chang; CHUN-JEN LIU; Dai, Chia Yen; Lin, Han Chieh; JIA-HORNG KAO; Chuang, Wan Long; Yu, Ming Lung |
| 臺大學術典藏 |
2022-01-15T00:07:46Z |
Hepatocellular carcinoma after treatment cessation in non-cirrhotic HBeAg-negative chronic hepatitis B: A multicentre cohort study
|
Papatheodoridi, Margarita; TUNG-HUNG SU; Hadziyannis, Emilia; Liao, Chun Hsun; Orfanidou, Αfroditi; Yang, Hung Chi; Zachou, Kalliopi; CHUN-JEN LIU; Kourikou, Anastasia; Gatselis, Nikolaos; Manolakopoulos, Spilios; Dalekos, George; JIA-HORNG KAO; Hadziyannis, Stephanos; Papatheodoridis, George V. |
| 臺大學術典藏 |
2021-12-14T23:12:17Z |
Hepatic steatosis and development of type 2 diabetes: Impact of chronic hepatitis B and viral specific factors
|
MING-WHEI YU; Lin, Chih Lin; CHUN-JEN LIU; YI-WEN HUANG; Hu, Jui Ting; Wu, Wan Jung; Wu, Chih Feng |
| 臺大學術典藏 |
2021-12-14T23:12:16Z |
Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR)
|
Huang, Chung Feng; Tseng, Kuo Chih; Cheng, Pin Nan; Hung, Chao Hung; Lo, Ching Chu; Peng, Cheng Yuan; Bair, Ming Jong; Yeh, Ming Lun; CHIEN-HUNG CHEN; Lee, Pei Lun; Lin, Chun Yen; Kuo, Hsing Tao; CHUN-TING CHEN; Yang, Chi Chieh; Huang, Jee Fu; Tai, Chi Ming; Hu, Jui Ting; Lin, Chih Lang; Su, Wei Wen; Tsai, Wei Lun; Huang, Yi Hsiang; Cheng, Chien Yu; Lin, Chih Lin; CHIA-CHI WANG; Yang, Sheng Shun; Mo, Lein Ray; Chen, Guei Ying; Chang, Chun Chao; Wang, Szu Jen; Huang, Chia Sheng; Hsieh, Tsai Yuan; Lin, Chih Wen; Lee, Tzong Hsi; Chong, Lee Won; Huang, Chien Wei; Chang, Shiuh Nan; Tsai, Ming Chang; Hsu, Shih Jer; JIA-HORNG KAO; CHUN-JEN LIU; CHEN-HUA LIU; Lin, Han Chieh; Lee, Mei Hsuan; Tsai, Pei Chien; Dai, Chia Yen; Chuang, Wan Long; Chen, Chi Yi; Yu, Ming Lung |
| 臺大學術典藏 |
2021-12-14T23:12:15Z |
Sofosbuvir/velpatasvir plus ribavirin for child-pugh b and child-pugh c hepatitis c virus-related cirrhosis
|
CHEN-HUA LIU; Chen, Chi Yi; Su, Wei Wen; CHUN-JEN LIU; Lo, Ching Chu; Huang, Ke Jhang; Chen, Jyh Jou; Tseng, Kuo Chih; Chang, Chi Yang; Peng, Cheng Yuan; Shih, Yu Lueng; Huang, Chia Sheng; Kao, Wei Yu; Yang, Sheng Shun; Tsai, Ming Chang; Wu, Jo Hsuan; Chen, Po Yueh; Su, Pei Yuan; Hwang, Jow Jyh; Fang, Yu Jen; Lee, Pei Lun; Tseng, Chi Wei; Lee, Fu Jen; Lai, Hsueh Chou; Hsieh, Tsai Yuan; Chang, Chun Chao; Chang, Chung Hsin; Huang, Yi Jie; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-12-14T23:11:58Z |
Kinetics of hepatitis B surface antigen in pregnant women with and without tenofovir disoproxil fumarate
|
Chang, Huai Lung; Wen, Wan Hsin; CHIEN-NAN LEE; Chiu, Yu En; CHUN-JEN LIU; MEI-HWEI CHANG; Lin, Lung Huang; HUEY-LING CHEN |
| 臺大學術典藏 |
2021-12-14T23:11:55Z |
Drug resistance profile and clinical features for hepatitis C patients experiencing DAA failure in Taiwan
|
CHUN-MING HONG; Lin, You Yu; CHUN-JEN LIU; Lai, Ya Yun; Shiou-Hwei Yeh; HUNG-CHIH YANG; JIA-HORNG KAO; Hsu, Shih Jer; Huang, Yi Hsiang; Yang, Sheng Shun; Kuo, Hsing Tao; Cheng, Pin Nan; Yu, Ming Lung; PEI-JER CHEN |
| 臺大學術典藏 |
2021-10-21T23:27:05Z |
Correction to: Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients (Hepatology International, (2021), 15, 3, (582-592), 10.1007/s12072-021-10186-7)
|
Cheng, Huei Ru; HUNG-CHIH YANG; Lin, Su Ru; Yang, Ta Yu; Lin, You Yu; TUNG-HUNG SU; Tseng, Tai Chung; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-10-21T23:27:05Z |
Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agents
|
Huang, Shang Chin; Cheng, Pin Nan; CHEN-HUA LIU; HUNG-CHIH YANG; TUNG-HUNG SU; Tseng, Tai Chung; PEI-JER CHEN; JIA-HORNG KAO; CHUN-JEN LIU |
| 臺大學術典藏 |
2021-09-14T23:18:55Z |
Changing epidemiology of liver disease in Asia: Dual infection of HBV and HCV
|
CHUN-JEN LIU; PEI-JER CHEN |
| 臺大學術典藏 |
2021-09-14T23:18:54Z |
Molecular mechanisms and animal models of HBV-related hepatocellular carcinoma: With emphasis on metastatic tumor antigen 1
|
Li, Yung Tsung; Wu, Hui Lin; CHUN-JEN LIU |
| 臺大學術典藏 |
2021-09-14T23:18:54Z |
Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)
|
Yeh, Ming Lun; Hung, Chao Hung; Tseng, Kuo Chih; Lai, Hsueh Chou; Chen, Chi Yi; Kuo, Hsing Tao; Wang, Jing Houng; Chen, Jyh Jou; Lee, Pei Lun; Chien, Rong Nan; Yang, Chi Chieh; Lo, Gin Ho; Tai, Chi Ming; Lin, Chih Wen; JIA-HORNG KAO; CHEN-HUA LIU; Yan, Sheng Lei; Bair, Ming Jong; Lin, Chun Yen; Su, Wei Wen; Chu, Cheng Hsin; Chen, Chih Jen; Tung, Shui Yi; Lo, Ching Chu; Cheng, Pin Nan; Chiu, Yen Cheng; CHIA-CHI WANG; Cheng, Jin Shiung; Tsai, Wei Lun; Lin, Han Chieh; Huang, Yi Hsiang; Huang, Chung Feng; Huang, Jee Fu; Dai, Chia Yen; Chuang, Wan Long; Tsai, Pei Chien; Peng, Cheng Yuan; CHUN-JEN LIU; Yu, Ming Lung |
| 臺大學術典藏 |
2021-09-14T23:18:28Z |
Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosis
|
TUNG-HUNG SU; Peng, Cheng Yuan; Chang, Shan Han; Tseng, Tai Chung; CHUN-JEN LIU; CHI-LING CHEN; CHEN-HUA LIU; HUNG-CHIH YANG; PEI-JER CHEN; JIA-HORNG KAO |
